This demonstrated that carcinogenic factors in ovarian cancer patients could be dramatically reduced by effective surgical treatment; besides, increased serum miR-21, HE4, and CA125 predisposed patients to recurrent or metastatic ovarian cancer. The gene discussed is WFDC2; the disease is ovarian cancer.